Upgrade to SI Premium - Free Trial

Armata Pharmaceuticals receives FDA fast track status for AP-SA02

May 7, 2026 7:00 AM
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) announced that the U.S. Food and Drug Administration has granted Fast Track Designation to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA